It has also been demonstrated that expression of H19 activates the mammalian target of rapamycin complex 1 signaling and the lipogenic transcription factor MLX interacting protein-like pathways, which are involved in hepatic steatosis production. This evidence concerns the gene H19 and fatty liver disease.